Janux Therapeutics Provides Program Update on Ongoing Phase 1 JANX008 Study
Go back to Janux Therapeutics Provides Program Update on Ongoing Phase 1 JANX008 Study| Janex International, Inc. (NASDAQ: JANX) | Delayed: 20.11 -0.13 (0.64%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $20.24 | 52 Week High | $0.01 | |||
| Open | $20.24 | 52 Week Low | $0.00 | |||
| Day High | $20.24 | P/E | N/A | |||
| Day Low | $19.67 | EPS | $0.00 | |||
| Volume | 156,481 | |||||
